Skip Ribbon Commands
Skip to main content

Primary Diagnosis

patent foramen ovale (PFO)

Study Purpose

This clinical study is intended to demonstrate the safety and effectiveness of the AMPLATZERTM PFO Occluder, in a post approval setting, in patients with a PFO who have had a cryptogenic stroke confirmed by a study neurologist.

Principal Investigator: Srinivasa Potluri MD

Trial Details

Locations: THHBP

Sponsor: Abbott

IRB Number: 018-025

Trial Status: Enrolling

Exclusions: Age 18-60

Change in Care: Participating in this study will change your care in that you could have additional lab work, diagnostic imaging, and follow-up visits

Contact Information:

Destiny Barnett, RN
469-814-4878
Destiny.Barnett@BSWHealth.org

Penni Dolton, RN
469-814-4735
Penni.Dolton@BSWHealth.org

Full Protocol Title

Amplatzer PFO Occluder Post Approval Study

Get Detailed Information On Clinicaltrials.gov »

BAYLOR SCOTT & WHITE RESEARCH ​INSTITUTE​​